These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 17874342

  • 1. [Significance and prospects of study on molecular alterations in oligodendrogliomas].
    Gresner SM, Liberski PP.
    Neurol Neurochir Pol; 2007; 41(4):333-9. PubMed ID: 17874342
    [Abstract] [Full Text] [Related]

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 3. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
    Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN.
    J Natl Cancer Inst; 1998 Oct 07; 90(19):1473-9. PubMed ID: 9776413
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: a descriptive study.
    Molinari C, Iorio P, Medri L, Ballardini M, Guiducci G, Cremonini AM, Cerasoli S, Riccioni L, Faedi M, Mariani GA, Zoli W, Silvestrini R, Calistri D.
    Int J Mol Med; 2010 Jan 07; 25(1):145-51. PubMed ID: 19956913
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity.
    Thiessen B, Maguire JA, McNeil K, Huntsman D, Martin MA, Horsman D.
    J Neurooncol; 2003 Sep 07; 64(3):271-8. PubMed ID: 14558604
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of chromosome 1p/19q loss of heterozygosity and Sox17 expression in oligodendrogliomas.
    Li J, Miao N, Liu M, Cui W, Liu X, Li X, Shi X, Qing S, Ma Y, Zhang W, Biekemituofu H.
    Int J Clin Exp Pathol; 2014 Sep 07; 7(12):8609-15. PubMed ID: 25674225
    [Abstract] [Full Text] [Related]

  • 9. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM, Rieske P, Wozniak K, Piaskowski S, Jaskolski DJ, Skowronski W, Golanska E, Sikorska B, Liberski PP.
    Clin Neuropathol; 2006 Sep 07; 25(1):18-24. PubMed ID: 16465770
    [Abstract] [Full Text] [Related]

  • 10. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity.
    Franco-Hernández C, Martínez-Glez V, de Campos JM, Isla A, Vaquero J, Gutiérrez M, Casartelli C, Rey JA.
    Cancer Genet Cytogenet; 2009 Apr 15; 190(2):93-6. PubMed ID: 19380026
    [Abstract] [Full Text] [Related]

  • 11. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
    Xiong J, Liu Y, Wang Y, Ke RH, Mao Y, Ye ZR.
    Chin Med J (Engl); 2010 Dec 15; 123(24):3566-73. PubMed ID: 22166632
    [Abstract] [Full Text] [Related]

  • 12. Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.
    Li S, Yan C, Huang L, Qiu X, Wang Z, Jiang T.
    Neuro Oncol; 2012 Jan 15; 14(1):109-16. PubMed ID: 22039037
    [Abstract] [Full Text] [Related]

  • 13. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.
    Hashimoto N, Murakami M, Takahashi Y, Fujimoto M, Inazawa J, Mineura K.
    Cancer; 2003 May 01; 97(9):2254-61. PubMed ID: 12712480
    [Abstract] [Full Text] [Related]

  • 14. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
    Gadji M, Fortin D, Tsanaclis AM, Drouin R.
    Cancer Genet Cytogenet; 2009 Oct 01; 194(1):12-22. PubMed ID: 19737649
    [Abstract] [Full Text] [Related]

  • 15. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
    Born PW, Broholm H, Laursen H.
    Ugeskr Laeger; 2006 Oct 30; 168(44):3813-6. PubMed ID: 17118240
    [Abstract] [Full Text] [Related]

  • 16. Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?
    Ramirez C, Bowman C, Maurage CA, Dubois F, Blond S, Porchet N, Escande F.
    Neuro Oncol; 2010 May 30; 12(5):490-9. PubMed ID: 20156805
    [Abstract] [Full Text] [Related]

  • 17. The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20 years' experience at a single centre.
    Parkinson JF, Afaghi V, Payne CA, Buckland ME, Brewer JM, Biggs MT, Little NS, Wheeler HR, Cook RJ, McDonald KL.
    J Clin Neurosci; 2011 Mar 30; 18(3):329-33. PubMed ID: 21247767
    [Abstract] [Full Text] [Related]

  • 18. Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival.
    Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R, Blaschke B, Schlegel U, Schramm J, Wiestler OD, Reifenberger G.
    Brain Pathol; 2004 Apr 30; 14(2):121-30. PubMed ID: 15193024
    [Abstract] [Full Text] [Related]

  • 19. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
    Huang L, Jiang T, Yuan F, Li GL, Xu LX, Cui Y.
    Zhonghua Zhong Liu Za Zhi; 2011 Oct 30; 33(10):752-8. PubMed ID: 22335907
    [Abstract] [Full Text] [Related]

  • 20. Loss of heterozygosity analysis in an anaplastic oligodendroglioma arising after radiation therapy.
    Hata N, Shono T, Mizoguchi M, Matsumoto K, Guan Y, Nagata S, Hayashi K, Iwaki T, Sasaki T.
    Neurol Res; 2007 Oct 30; 29(7):723-6. PubMed ID: 17553214
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.